BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19092731)

  • 1. A head-tilt test for hypopyon after intravitreal triamcinolone.
    Mahajan VB; Folk JC; Boldt HC
    Retina; 2009 Apr; 29(4):560-1. PubMed ID: 19092731
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinguishing between infectious and noninfectious endophthalmitis after intravitreal triamcinolone injection.
    Roth DB; Flynn HW
    Am J Ophthalmol; 2008 Sep; 146(3):346-347. PubMed ID: 18724979
    [No Abstract]   [Full Text] [Related]  

  • 3. Steroid hypopyon following intravitreal triamcinolone acetonide injection in a pseudophakic patient.
    Amato JE; Lee DH; Santos BA; Akduman L
    Ocul Immunol Inflamm; 2005; 13(2-3):245-7. PubMed ID: 16019686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
    Yoon SJ; Rhee DY; Marx JL; Blaha GR; Rogers AH; Baumal CR; Reichel E; Duker JS
    Am J Ophthalmol; 2009 Jun; 147(6):1031-6. PubMed ID: 19268893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006.
    Stepien KE; Eaton AM; Jaffe GJ; Davis JL; Raja J; Feuer W
    Retina; 2009 Feb; 29(2):207-13. PubMed ID: 19050670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A head-tilt test for hypopyon after intravitreal triamcinolone.
    Chen SD
    Retina; 2009 Sep; 29(8):1210-1; author reply 1211. PubMed ID: 19734769
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis.
    Tay-Kearney ML
    Ocul Immunol Inflamm; 2006 Aug; 14(4):201-2. PubMed ID: 16911980
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute endophthalmitis incidence: intravitreal triamcinolone.
    Westfall AC; Osborn A; Kuhl D; Benz MS; Mieler WF; Holz ER
    Arch Ophthalmol; 2005 Aug; 123(8):1075-7. PubMed ID: 16087840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravitreal triamcinolone therapy. New therapeutic alternative for patients with vision-threatening eye diseases].
    Klitgaard TL; Haamann PH; Villumsen JE; Larsen M
    Ugeskr Laeger; 2005 Apr; 167(16):1729-31. PubMed ID: 15898599
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacterial endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy.
    Mitamura Y; Miyano N; Ohtsuka K
    Jpn J Ophthalmol; 2005; 49(6):538-539. PubMed ID: 16365807
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravitreal use of triamcinolone acetonide: an experimental clinical procedure.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Oct; 83(5):526-7. PubMed ID: 16187987
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical characteristics and incidence of infectious and non-infectious endophthalmitis after intravitreous injection of triamcinolone acetonide].
    Magalhães E; Nehemy P; Santos DV; Fujji G; Nehemy MB
    Arq Bras Oftalmol; 2006; 69(6):791-4. PubMed ID: 17273669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argon laser trabeculoplasty for late glaucoma after intravitreal triamcinolone.
    Chen WL; Tsai YY; Chiang CC; Lin JM
    Acta Ophthalmol; 2009 Mar; 87(2):238-9. PubMed ID: 19292859
    [No Abstract]   [Full Text] [Related]  

  • 14. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
    Kamppeter BA; Cej A; Jonas JB
    Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of intravitreal triamcinolone acetonide.
    Erol N; Topba S
    Surv Ophthalmol; 2009; 54(3):427; author reply 427-8. PubMed ID: 19422973
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and pathologic features of Bipolaris endophthalmitis after intravitreal triamcinolone.
    Minckler D; Small KW; Walsh TJ
    JAMA Ophthalmol; 2014 May; 132(5):630-2. PubMed ID: 24626426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.
    Hosseini H; Mehryar M; Eghtedari M; Ahmadi F; Nowroozizadeh S
    Curr Eye Res; 2009 Feb; 34(2):145-51. PubMed ID: 19219686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of triamcinolone acetonide, 11-deoxycortisol and other lipid formulae for the visualization of vitreous body in the anterior chamber after posterior capsule rupture in animal models.
    Kaji Y; Hiraoka T; Okamoto F; Asano H; Oshika T
    Acta Ophthalmol; 2008 Feb; 86(1):97-102. PubMed ID: 17908254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudohypopyon following intravitreal triamcinolone acetonide injection.
    Sharma MC; Lai WW; Shapiro MJ
    Cornea; 2004 May; 23(4):398-9. PubMed ID: 15097137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presumed Sterile Endophthalmitis Afer Intravitreal Triamcinolone (Kenalog)-More Common and Less Benign Than We Thought?
    Fong AH; Chan CK
    Asia Pac J Ophthalmol (Phila); 2017; 6(1):45-49. PubMed ID: 28161929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.